The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xiang, Z. Q.
Right arrow Articles by Ertl, H. C. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xiang, Z. Q.
Right arrow Articles by Ertl, H. C. J.
Right arrowPubmed/NCBI databases
*Substance via MeSH
The Journal of Immunology, 1999, 162: 6716-6723.
Copyright © 1999 by The American Association of Immunologists

Induction of Genital Immunity by DNA Priming and Intranasal Booster Immunization with a Replication-Defective Adenoviral Recombinant1

Zhi Quan Xiang, Susanna Pasquini2 and Hildegund C. J. Ertl3

Wistar Institute, Philadelphia, PA 19104

Mice immunized through different routes such as i.m., intradermally, or intratracheally with a DNA vaccine to rabies virus developed high titers of serum Ab but only borderline levels of mucosal Abs determined from vaginal secretions. DNA vaccines given by either route enhanced vaginal IgA and IgG2a secretion upon a subsequent intranasal booster immunization with an E1-deleted adenoviral recombinant expressing the same Ag of rabies virus. DNA vaccine priming reduced the Ab response to the adenoviral Ags and counterbalanced the impaired B cell response to the rabies virus Ag expressed by the adenoviral recombinant in mice preimmune to adenovirus. The vaginal B cell response could further be enhanced by using the Th2-type cytokines IL-4 or IL-5 as genetic adjuvants concomitantly with the DNA vaccine before intranasal booster immunization with the recombinant vaccine.




This article has been cited by other articles:


Home page
J. Virol.Home page
W.-p. Kong, L. Xu, K. Stadler, J. B. Ulmer, S. Abrignani, R. Rappuoli, and G. J. Nabel
Modulation of the Immune Response to the Severe Acute Respiratory Syndrome Spike Glycoprotein by Gene-Based and Inactivated Virus Immunization
J. Virol., November 15, 2005; 79(22): 13915 - 13923.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
L. Wu, W.-p. Kong, and G. J. Nabel
Enhanced Breadth of CD4 T-Cell Immunity by DNA Prime and Adenovirus Boost Immunization to Human Immunodeficiency Virus Env and Gag Immunogens
J. Virol., July 1, 2005; 79(13): 8024 - 8031.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. O. Lasaro, W. B. Luiz, M. E. Sbrogio-Almeida, L. S. Nishimura, B. E. C. Guth, and L. C. S. Ferreira
Combined Vaccine Regimen Based on Parenteral Priming with a DNA Vaccine and Administration of an Oral Booster Consisting of a Recombinant Salmonella enterica Serovar Typhimurium Vaccine Strain for Immunization against Infection with Human-Derived Enterotoxigenic Escherichia coli Strains
Infect. Immun., November 1, 2004; 72(11): 6480 - 6491.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. R. Pinto, J. C. Fitzgerald, W. Giles-Davis, G. P. Gao, J. M. Wilson, and H. C. J. Ertl
Induction of CD8+ T Cells to an HIV-1 Antigen through a Prime Boost Regimen with Heterologous E1-Deleted Adenoviral Vaccine Carriers
J. Immunol., December 15, 2003; 171(12): 6774 - 6779.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
Z. Q. Xiang, G. P. Gao, A. Reyes-Sandoval, Y. Li, J. M. Wilson, and H. C. J. Ertl
Oral Vaccination of Mice with Adenoviral Vectors Is Not Impaired by Preexisting Immunity to the Vaccine Carrier
J. Virol., October 15, 2003; 77(20): 10780 - 10789.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Z. Xiang, Y. Li, G. Gao, J. M. Wilson, and H. C. J. Ertl
Mucosally Delivered E1-Deleted Adenoviral Vaccine Carriers Induce Transgene Product-Specific Antibody Responses in Neonatal Mice
J. Immunol., October 15, 2003; 171(8): 4287 - 4293.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
F. Lemiale, W.-p. Kong, L. M. Akyurek, X. Ling, Y. Huang, B. K. Chakrabarti, M. Eckhaus, and G. J. Nabel
Enhanced Mucosal Immunoglobulin A Response of Intranasal Adenoviral Vector Human Immunodeficiency Virus Vaccine and Localization in the Central Nervous System
J. Virol., September 15, 2003; 77(18): 10078 - 10087.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
Z. Xiang, G. Gao, A. Reyes-Sandoval, C. J. Cohen, Y. Li, J. M. Bergelson, J. M. Wilson, and H. C. J. Ertl
Novel, Chimpanzee Serotype 68-Based Adenoviral Vaccine Carrier for Induction of Antibodies to a Transgene Product
J. Virol., February 22, 2002; 76(6): 2667 - 2675.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
C. J. Cohen, Z. Q. Xiang, G.-P. Gao, H. C. J. Ertl, J. M. Wilson, and J. M. Bergelson
Chimpanzee adenovirus CV-68 adapted as a gene delivery vector interacts with the coxsackievirus and adenovirus receptor
J. Gen. Virol., January 1, 2002; 83(1): 151 - 155.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.